Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer

This study has suspended participant recruitment.
(The study is suspended until further information regarding safety is received)
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Hellenic Cooperative Oncology Group
ClinicalTrials.gov Identifier:
NCT01855724
First received: May 14, 2013
Last updated: July 29, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: November 2016
  Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)